Investor Says K-V Lied About Pregnancy Drug's Prospects
A K-V Pharmaceutical Co. shareholder filed a putative class action in Missouri on Wednesday claiming the drugmaker lied to investors about prospects for pregnancy drug Makena, artificially inflating the stock price...To view the full article, register now.
Already a subscriber? Click here to view full article